PL2473482T3 - Metody leczenia zakażeń ortomyksowirusowych - Google Patents
Metody leczenia zakażeń ortomyksowirusowychInfo
- Publication number
- PL2473482T3 PL2473482T3 PL10814409T PL10814409T PL2473482T3 PL 2473482 T3 PL2473482 T3 PL 2473482T3 PL 10814409 T PL10814409 T PL 10814409T PL 10814409 T PL10814409 T PL 10814409T PL 2473482 T3 PL2473482 T3 PL 2473482T3
- Authority
- PL
- Poland
- Prior art keywords
- orthomyxoviral
- infections
- treating
- methods
- treating orthomyxoviral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27225409P | 2009-09-04 | 2009-09-04 | |
| US28250810P | 2010-02-22 | 2010-02-22 | |
| US35393510P | 2010-06-11 | 2010-06-11 | |
| EP10814409.8A EP2473482B1 (en) | 2009-09-04 | 2010-09-01 | Methods of treating orthomyxoviral infections |
| PCT/US2010/047488 WO2011028775A1 (en) | 2009-09-04 | 2010-09-01 | Methods of treating orthomyxoviral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2473482T3 true PL2473482T3 (pl) | 2014-09-30 |
Family
ID=43649616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10814409T PL2473482T3 (pl) | 2009-09-04 | 2010-09-01 | Metody leczenia zakażeń ortomyksowirusowych |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110065752A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2473482B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5653438B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101497194B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102625796B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012004676A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2772875A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2473482T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2466027T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012002486A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2473482T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011028775A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2579628T3 (es) | 2009-02-23 | 2016-08-12 | Emergent Virology Llc | Iminoazúcares y métodos de tratamiento de enfermedades virales |
| CA2875975A1 (en) | 2012-06-06 | 2013-12-12 | Unither Virology, Llc | Novel iminosugars and their applications |
| CA2924026C (en) * | 2013-09-16 | 2021-12-28 | Emergent Virology Llc | Deoxynojirimycin derivatives and methods of their using |
| CA2966893C (en) | 2014-11-05 | 2023-10-24 | Emergent Virology Llc | Iminosugars |
| WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
| EP3934688A4 (en) * | 2019-03-08 | 2022-12-21 | University of Virginia Patent Foundation | COMPOSITIONS AND METHODS FOR MODULATION OF VIRAL INFECTION THROUGH REGULATION OF GLUCOSYLCERAMIDS |
| CN111904959A (zh) * | 2020-08-21 | 2020-11-10 | 牡丹江医学院 | α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途 |
| IT202200007808A1 (it) * | 2022-04-20 | 2023-10-20 | Luigi Michele Pavone | Composizioni terapeutiche per malattie causate da accumulo di eparan solfato |
| CN119841765B (zh) * | 2025-01-09 | 2025-10-10 | 中南大学 | Dnj衍生物、药物组合物及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8013A (en) * | 1851-04-01 | Improvement in wheat-fans | ||
| GB1555654A (en) * | 1977-06-25 | 1979-11-14 | Exxon Research Engineering Co | Agricultural burner apparatus |
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| DE2834122A1 (de) * | 1978-08-03 | 1980-02-14 | Bayer Ag | Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose |
| DE2839309A1 (de) * | 1978-09-09 | 1980-03-27 | Bayer Ag | 3,4,5-trihydroxypiperidin-derivate |
| DE2853573A1 (de) * | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
| DE3038901A1 (de) * | 1980-10-15 | 1982-05-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins |
| DE3611841A1 (de) * | 1986-04-09 | 1987-10-15 | Bayer Ag | Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten |
| US5043273A (en) * | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
| US5103008A (en) * | 1989-08-17 | 1992-04-07 | Monsanto Company | Compound, N-butyl-deoxynojirimycin-6-phosphate |
| US4994572A (en) * | 1989-10-12 | 1991-02-19 | Monsanto Company | Synthesis of nojirimycin derivatives |
| US5030638A (en) * | 1990-02-26 | 1991-07-09 | G. D. Searle & Co. | Method of antiviral enhancement |
| US5200523A (en) * | 1990-10-10 | 1993-04-06 | Monsanto Company | Synthesis of nojirimycin derivatives |
| US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
| US5399567A (en) * | 1993-05-13 | 1995-03-21 | Monsanto Company | Method of treating cholera |
| AU1876095A (en) * | 1994-02-25 | 1995-09-11 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
| AU761748B2 (en) * | 1997-12-11 | 2003-06-12 | Chancellor, Masters And Scholars Of The University Of Oxford, The | Inhibition of membrane-associated viral replication |
| US6689759B1 (en) * | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
| US6610703B1 (en) * | 1998-12-10 | 2003-08-26 | G.D. Searle & Co. | Method for treatment of glycolipid storage diseases |
| GB9828474D0 (en) * | 1998-12-24 | 1999-02-17 | British Aerospace | Surface topology inspection |
| ES2311921T3 (es) * | 1999-02-12 | 2009-02-16 | United Therapeutics Corporation | N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis. |
| GB0100889D0 (en) * | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
| JP2003505430A (ja) * | 1999-07-26 | 2003-02-12 | ジー・ディー・サール・アンド・カンパニー | デオキシノジリマイシンの長鎖n−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用 |
| DE60037664T2 (de) * | 1999-08-10 | 2008-12-24 | The Chancellor, Masters And Scholars Of The University Of Oxford | Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel |
| US7256005B2 (en) * | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
| JP5589165B2 (ja) * | 2003-01-31 | 2014-09-17 | マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー | タンパク質欠損性障害の治療のための併用療法 |
| US7446098B2 (en) * | 2003-02-18 | 2008-11-04 | Mount Sinai School Of Medicine Of New York University | Combination therapy for treating protein deficiencies |
| US20050256168A1 (en) * | 2004-04-28 | 2005-11-17 | Block Timothy M | Compositions for oral administration for the treatment of interferon-responsive disorders |
| US7524829B2 (en) * | 2004-11-01 | 2009-04-28 | Avi Biopharma, Inc. | Antisense antiviral compounds and methods for treating a filovirus infection |
| GB0501352D0 (en) * | 2005-01-21 | 2005-03-02 | Slingsby Jason H | Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope |
| CA2601797A1 (en) * | 2005-03-16 | 2006-09-21 | University Of Oxford | Mannose immunogens for hiv-1 |
| EP3782655A1 (en) * | 2005-05-17 | 2021-02-24 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| BRPI0615974A2 (pt) * | 2005-07-27 | 2011-05-31 | University Of Florida Research Foundation, Inc., | uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular |
| CN101267779A (zh) * | 2005-07-27 | 2008-09-17 | 福罗里达大学研究基金会有限公司 | 使用热休克治疗眼睛疾病 |
| US20070244184A1 (en) * | 2006-01-09 | 2007-10-18 | Simon Fraser University | Glycosidase inhibitors and methods of synthesizing same |
| DE602007008870D1 (de) * | 2006-04-24 | 2010-10-14 | Amc Amsterdam | Verbessertes verfahren zur behandlung von cystischer fibrose |
| CN101489554A (zh) * | 2006-05-24 | 2009-07-22 | 联合治疗公司 | 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法 |
| CN102727437A (zh) * | 2006-08-02 | 2012-10-17 | 牛津大学院长校长专家委员会 | 病毒感染的脂质体治疗 |
| CA2666814A1 (en) * | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
| CN101172127B (zh) * | 2006-10-31 | 2011-12-07 | 上海市新文达生物科技有限公司 | 一种桑叶提取物及其在制备抗甲型流感病毒药物中的应用 |
| KR20100127842A (ko) * | 2008-03-26 | 2010-12-06 | 유니버시티 오브 옥스퍼드 | 소포체 표적화 리포좀 |
| CN101278977B (zh) * | 2008-03-31 | 2012-05-30 | 广州唐百服生物科技有限公司 | 一种桑叶主要活性成分的提取方法及其提取物用途 |
-
2010
- 2010-09-01 EP EP10814409.8A patent/EP2473482B1/en not_active Not-in-force
- 2010-09-01 MX MX2012002486A patent/MX2012002486A/es active IP Right Grant
- 2010-09-01 CN CN201080048403.3A patent/CN102625796B/zh not_active Expired - Fee Related
- 2010-09-01 DK DK10814409.8T patent/DK2473482T3/da active
- 2010-09-01 PL PL10814409T patent/PL2473482T3/pl unknown
- 2010-09-01 KR KR1020127007709A patent/KR101497194B1/ko not_active Expired - Fee Related
- 2010-09-01 JP JP2012528002A patent/JP5653438B2/ja not_active Expired - Fee Related
- 2010-09-01 CA CA2772875A patent/CA2772875A1/en not_active Abandoned
- 2010-09-01 BR BR112012004676A patent/BR112012004676A2/pt not_active IP Right Cessation
- 2010-09-01 ES ES10814409.8T patent/ES2466027T3/es active Active
- 2010-09-01 US US12/873,704 patent/US20110065752A1/en not_active Abandoned
- 2010-09-01 WO PCT/US2010/047488 patent/WO2011028775A1/en not_active Ceased
-
2016
- 2016-05-04 US US15/145,981 patent/US20160243096A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120080584A (ko) | 2012-07-17 |
| MX2012002486A (es) | 2012-09-07 |
| CN102625796A (zh) | 2012-08-01 |
| CN102625796B (zh) | 2015-03-11 |
| JP2013503880A (ja) | 2013-02-04 |
| KR101497194B1 (ko) | 2015-02-27 |
| BR112012004676A2 (pt) | 2019-09-24 |
| EP2473482A4 (en) | 2013-01-16 |
| WO2011028775A1 (en) | 2011-03-10 |
| CA2772875A1 (en) | 2011-03-10 |
| EP2473482B1 (en) | 2014-03-05 |
| US20110065752A1 (en) | 2011-03-17 |
| US20160243096A1 (en) | 2016-08-25 |
| ES2466027T3 (es) | 2014-06-09 |
| EP2473482A1 (en) | 2012-07-11 |
| JP5653438B2 (ja) | 2015-01-14 |
| DK2473482T3 (en) | 2014-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3269A (en) | Methods and compounds for treating paramyxoviridaevirus infections | |
| ZA201006648B (en) | Methods of treatment | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| IL207170A0 (en) | Methods of treating viral infections | |
| PT2435825E (pt) | Métodos para o tratamento de doenças | |
| IL214664A0 (en) | Methods of treating hair related conditions | |
| GB0919097D0 (en) | Treatment of hard surfaces | |
| GB201018147D0 (en) | Method of treatment | |
| EP2480579A4 (en) | METHODS OF TREATING INFLAMMATION | |
| IL206491A0 (en) | Treatment of produce | |
| DK2473482T3 (en) | Methods of treating orthomyxoviral infections | |
| ZA201206636B (en) | Treatment of streptococcal infections | |
| IL256026B (en) | Treatment methods | |
| EP2473493A4 (en) | METHODS OF TREATING POXVIRAL INFECTIONS | |
| PT2424559T (pt) | Métodos de tratamento de infeções bacterianas utilizando oritavancina | |
| ZA201204249B (en) | Treatment of microbial infections | |
| EP2560679A4 (en) | TREATMENT OF ECZEMA | |
| GB201018149D0 (en) | Method of treatment | |
| EP2585103A4 (en) | METHOD OF TREATMENT | |
| GB201020015D0 (en) | Method of treatment | |
| IL216456A0 (en) | Method of treating frailty | |
| EP2424539A4 (en) | PROCESS FOR TREATING DEPRESSION | |
| GB0904164D0 (en) | Method of treatment | |
| GB0921823D0 (en) | Method of treatment | |
| GB0909807D0 (en) | Method of treatment |